Show Notes
Stephen Ryu, a neurosurgeon and key figure in the Stanford Neuroprosthetics Lab joins Tjaša Zajc on Faces of Digital Health to demystify brain–computer interfaces (BCIs): how they work, why invasive systems outperform non-invasive ones, realistic use cases (motor control and speech), timelines and durability, safety and MRI trade-offs, cybersecurity, business models, and what Paradromics is building as a high-bandwidth BCI platform.
Throughout, Stephen separates science fact from sci-fi, stressing near-term potential to restore communication and movement for people living with paralysis, while noting earlier-stage areas like mental health and pain.
What we cover: - Invasive vs. non-invasive BCIs, and why electrode proximity to neurons matters for performance - Decoding motor intent and speech: training, language considerations, and LLM-enabled synthesis - Safety, surgery, and durability (why 10-year implant lifespans are a meaningful target) - MRI/CT compatibility trade-offs (and parallels to pacemakers/DBS) - Cybersecurity realities (what BCIs can not do today) - Business models, regulation, and reimbursement paths for medical-grade BCIs - Paradromics’ differentiation: a high-bandwidth platform designed to scale across use cases - Future indications: pain, sensory restoration; earlier stage: mental health biomarkers - The human impact: restoring connection for people who can’t move or speak
Chapters:
01:37 How BCIs work; signals, decoding, invasive vs. non-invasive 07:13 Surgery basics, risks, and why proximity boosts performance 09:36 Decoding speech & language considerations 13:31 What’s most advanced today: motor + speech 14:58 Mental health: biomarkers and why it’s early 17:48 Longevity, MRI/CT limits, realistic replacement intervals 21:16 Patient perception: fear, performance, and value vs. alternatives 25:04 Paradromics’ platform & high-bandwidth approach 29:22 Platform use cases by brain area (motor, auditory, etc.) 31:18 Cybersecurity: risks today vs. sci-fi 32:35 Business models, regulation, and access 36:42 Trials landscape; Paradromics’ timeline 37:53 Biggest concerns: hype vs. reality 39:50 Three things everyone should know about BCIs 42:10 Potential in pain management 44:41 Role of AI/ML in decoding and assistive apps 46:36 Final thoughts
www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/
More from Faces of Digital Health
Three in ten AI pilots at Sheba Medical Center never scale. Eyal Zimlichman on why, and what Europe's regulation holds back.
When prevention works, nothing happens. That's why it gets cut. Joanna Lane on financing prevention as long-term investment.
Nearly €200m, twenty years of EU health data projects. Henrique Martins on what they built and what EHDS needs next.
One ultrasound tech, four scanning rooms. NVIDIA's David Niewolny on what "augmented autonomy" asks of clinicians.
Most interoperability debates focus on exchange formats. In this discussion with Dr Nils Hellrung, medical informatician and CEO Strategy & Operations at vitagroup, Nils focuses on the need for shaping hospital IT with governance and financing.